TSB LATEST NEWS
TheraSyn Bio and Rubix LS Announce Joint Venture on Project Panacea, a Novel Topical Breast Cancer Therapy
https://www.linkedin.com/posts/therasyn-bio-inc_tsb-announcement-of-project-panacea-activity-7292225224895299585-0PqC/?utm_source=share&utm_medium=member_desktop
University of Memphis Partners with TheraSyn Bio to Advance Synthetic Biology Research in Biomedical, Bioscience, Cybersecurity Fields https://www.memphis.edu/mediaroom/releases/2023/november/university-of-memphis-partners-with-therasyn.php
Files coming soon.
PRESS RELEASE
Copyright © 2024-2034 TheraSyn Bio Inc - All Rights Reserved. Therasyn Bio Inc. IS A COPYRIGHT AND REGISTERED TRADEMARKED Company-
60 Island Street, Lawrence, Mass. 01840 - 100% Owned & Operated US Corporation - UEI X28FBXVY5J98 - Cage Code 9CDTO
Announcement
To stay updated on all of the latest news and workings of TSB, you can subscribe below.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.